Sakthivel Muthu | Biochemistry, Genetics and Molecular Biology | Best Faculty Award

Posted on by Book of Award

Dr. Sakthivel Muthu | Biochemistry, Genetics and Molecular Biology | Best Faculty Award

Saveetha Medical College and Hospital | India

Author profile

Scopus

Orcid

Google Scholar

🎓 Early Academic Pursuits

Dr. Sakthivel Muthu’s academic journey began with a Bachelor's degree in Botany from Madurai Kamaraj University in 2005. He continued his education with an M.Sc. in Botany in 2007 and an M.Phil. in Botany from the University of Madras in 2008. His deep interest in plant sciences culminated in a Ph.D. in Botany from the University of Madras in 2016, where his thesis was highly commended.

👨‍🏫 Professional Endeavors

Dr. Muthu's professional career took off as a Post-Doctoral Fellow in Biotechnology at the University of Madras, supported by the prestigious UGC fellowship (2017–2022). He later transitioned into academia as a Guest Faculty member in Biotechnology at the same institution in 2023, bringing his expertise in bioactive compounds and protein biochemistry to students and peers alike.

🔬 Contributions and Research Focus

With a strong passion for interdisciplinary collaboration, Dr. Muthu has delved into various research fields, including protein biochemistry, enzymology, and bioactive compounds from plants and marine algae. His work extends to microbiology and cancer biology, aiming to unlock new therapeutic approaches through natural compounds. His notable contributions include research on phloroglucinol encapsulation for lung cancer and the antibacterial properties of lysozymes.

🏆 Accolades and Recognition

Dr. Muthu's contributions to science have been recognized with multiple awards and fellowships, such as:

  • UGC Post-Doctoral Fellowship (2017–2022)
  • Project Fellowship under the UGC’s BSR Fellowships (2010–2015)

He has also published several high-impact research papers in internationally renowned journals, contributing to fields like nanotechnology, enzymology, and phytochemistry.

🌍 Impact and Influence

Dr. Muthu's research has had a broad influence, particularly in understanding the bioactive properties of natural compounds and their potential in areas like cancer therapy and antibacterial applications. His work with nanoparticles and natural enzyme extraction has provided significant insights into sustainable biotechnological solutions.

🏅 Legacy and Future Contributions

Looking ahead, Dr. Muthu’s dedication to innovative biotechnological research and his willingness to collaborate across disciplines ensure that his contributions to science will continue to inspire future researchers. His ongoing projects, publications, and involvement in patent applications reflect his unwavering commitment to advancing our understanding of biochemistry and biotechnology.

 

Publications

  • 📄 Encapsulation of Phloroglucinol from Rosenvingea intricata Macroalgae with Zinc Oxide Nanoparticles against A549 Lung Cancer Cells
    • Journal: Pharmaceutics
    • Date: 2024-10-05
    • Authors: Sakthivel Muthu, Mythileeswari Lakshmikanthan, Edwin Edward-Sam, Mutheeswaran Subramanian, Lakshmanan Govindan, Afrina Begum Mithen Patcha, Kathiravan Krishnan, Nallusamy Duraisamy, Selvakumari Jeyaperumal, Al Thabiani Aziz
  • 📄 A Comprehensive Review on Anthocyanin-rich Foods: Insights into Extraction, Medicinal Potential, and Sustainable Applications
    • Journal: Journal of Agriculture and Food Research
    • Date: 2024-06
    • Authors: Mythileeswari Lakshmikanthan, Sakthivel Muthu, Kathiravan Krishnan, Ammar B. Altemimi, Noor N. Haider, Lakshmanan Govindan, Jeyaperumal Selvakumari, Zina T. Alkanan, Francesco Cacciola, Yuvaraj Maria Francis
  • 📄 A Bioflocculant Made from Chitosan and Modified Shrimp Waste Might Collect Fresh and Saltwater Microalgae
    • Journal: Biosciences Biotechnology Research Asia
    • Date: 2024-03-30
    • Authors: Nallusamy Duraisamy, Sakthivel Muthu, Kumaran Thangavel, Kathiravan Krishnan, Sivamalar Sathasivam
  • 📄 Extraction, Purification, and Investigation of the Antibacterial Potential of Lysozyme Isolated from the Latex of Calotropis procera
    • Journal: European Food Research and Technology
    • Date: 2024-02-21
    • Authors: Sakthivel Muthu, Venkateshbabu Gopal, Zena Kadhim AL-Younis, Ammar B. Altemimi, Palani Perumal, Mythileeswari Lakshmikanthan, Kathiravan Krishnan, Mazin A. A. Najm, Angelo Maria Giuffrè, Lakshmanan Govindan
  • 📄 Viral Diseases of Ornamental Plants-III
    • Journal: Viral Diseases of Field and Horticultural Crops (Book Chapter)
    • Date: 2023
    • Authors: D. Sundararaj, S. Pushpanathan, S. Muthu, K. Krishnan

 

Dong Hyun Kim | Medicine and Dentistry | Young Scientist Award

Posted on by Book of Award

Dr. Dong Hyun Kim | Medicine and Dentistry | Young Scientist Award

Seoul National University College of Medicine | South Korea

Author Profile

Scopus

Orcid

Early Academic Pursuits 🎓

Dr. Dong Hyun Kim embarked on his medical journey at the prestigious Seoul National University College of Medicine, earning his Bachelor of Medicine in 2019. His academic rigor continued with a Master's degree in Medical Science, specializing in Translational Medicine, which he completed in 2024. His academic training laid the foundation for his future endeavors in clinical oncology and hematologic malignancies, blending medicine with cutting-edge research.

Professional Endeavors 🏥

Dr. Kim's professional career began at Seoul National University Hospital, where he completed his internship and then advanced to a Resident Doctor position in the Department of Internal Medicine. His expertise expanded into the field of Hemato-Oncology, where he currently serves as an External Clinical Researcher. His clinical work, especially in the realm of cancer treatment and translational medicine, has contributed significantly to patient care and scientific discovery.

Contributions and Research Focus 🔬

Dr. Kim’s research has made a considerable impact on hematologic malignancies and the use of artificial intelligence in oncology. His work spans various domains, including allogeneic stem cell transplantation, tumor-infiltrating lymphocytes as biomarkers, and predictive modeling in cancer treatment. Through his numerous publications, he has explored innovative treatments and personalized medicine, particularly focusing on improving patient outcomes in myelofibrosis, thymic epithelial neoplasms, and head and neck squamous cell carcinoma.

Accolades and Recognition 🏅

Dr. Kim has received numerous awards that underscore his contributions to the field. He earned the Best Oral Presentation Award at ICBMT 2022, a Presidential Oral Presentation at JSMO 2024, and another Best Oral Presentation Award at ICKSH 2024. These recognitions reflect his leadership in oncology research and his ability to present complex ideas with clarity and authority.

Impact and Influence 🌍

Through his published works, Dr. Kim has influenced the global oncology community. His research on artificial intelligence in oncology, predictive biomarkers, and innovative therapeutic approaches has opened new pathways in cancer treatment. His contributions, especially in improving treatment strategies for hematologic malignancies and solid tumors, are helping shape the future of personalized medicine.

Legacy and Future Contributions 🌟

Dr. Kim is poised to continue influencing the fields of clinical oncology and translational medicine. His dedication to research, combined with his clinical expertise, ensures that he will remain a key figure in advancing cancer treatment and improving patient outcomes. His future endeavors, backed by a solid academic and professional foundation, are expected to further elevate the standards of oncological care and research.

Publications

📄 Dual T-cell depletion with individually tailored anti-thymocyte globulin and attenuated dose of post-transplant cyclophosphamide in haploidentical peripheral stem cell transplantation
Author: Kim, D.H., Shin, D.-Y., Koh, Y., Byun, J.M., Hong, J.
Journal: Scientific Reports
Year: 2024

📄 Effects of tertiary palliative care on the pattern of end-of-life care in patients with hematologic malignancies in Korea
Author: Kim, D.H., Youk, J., Byun, J.M., Yoo, S.H., Shin, D.-Y.
Journal: European Journal of Haematology
Year: 2024

📄 Impact of PIK3CA and cell cycle pathway genetic alterations on durvalumab efficacy in patients with head and neck squamous cell carcinoma: Post hoc analysis of TRIUMPH study
Author: Kim, D.H., Lim, S.T., Kim, H.R., Shin, S.-H., Yun, H.J.
Journal: Oral Oncology
Year: 2024

📄 Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes as a predictive biomarker for axitinib in adenoid cystic carcinoma
Author: Kim, D.H., Lim, Y., Ock, C.-Y., Kim, S.-B., Keam, B.
Journal: Head and Neck
Year: 2023

 

Jairus Nandwa | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Posted on by Book of Award

Mr. Jairus Nandwa | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Hebrew University of Jerusalem | Israel

Author Profile

Scopus

Orcid

Early Academic Pursuits

Mr. Jairus Nandwa embarked on his academic journey with a Bachelor of Technology in Industrial Microbiology and Biotechnology from The Technical University of Mombasa, Kenya. He further pursued a Master of Science in Biosciences at COMSATS University Islamabad, Pakistan, and is currently pursuing a PhD in Genetics at The Hebrew University of Jerusalem, focusing on circular RNAs, SNORDS, and miRNAs in cancer under the guidance of Professor Ruth Sperling.

Professional Endeavors

With a robust academic background, Mr. Nandwa engaged in various research experiences, including his role as a Graduate Student/Research Student at the Cancer Genetics and Epigenetics Lab, COMSATS University, Pakistan. He also served as a Laboratory Analyst during his BTech internship at the Regional Veterinary Investigation Laboratory, Kenya.

Contributions and Research Focus

Mr. Nandwa's research interests span non-coding RNAs in gene expression regulation, tumor microenvironment, biomarker/therapeutic discovery, DNA repair mechanisms, and biological data analysis. He has authored several publications and presented his research at esteemed conferences globally.

Accolades and Recognition

His notable publications include research on miRNA-4716–3p and its association with blood cancer pathogenesis, earning recognition in Non-Coding RNA Research. He has also received awards such as the Queen Elizabeth Commonwealth Scholarship and First Class Honors in BTech Industrial Microbiology and Biotechnology.

Impact and Influence

Mr. Nandwa's contributions extend beyond academia, with leadership roles in cancer education initiatives and community service engagements. His research and volunteer efforts demonstrate a commitment to advancing scientific knowledge and addressing societal challenges.

Legacy and Future Contributions

As Mr. Nandwa continues his doctoral studies and research pursuits, his dedication to understanding the intricacies of cancer biology and contributing to innovative solutions positions him as a promising researcher in the field of genetics. His leadership, academic achievements, and community impact foreshadow a legacy of scientific excellence and social responsibility.

Notable Publications

miR-4716–3p and the target AKT2 Gene/rs2304186 SNP are associated with blood cancer pathogenesis in Pakistani population 2024

In silico analysis of RPS4X (X-linked ribosomal protein) with active components from black seed (Nigella sativa) for potential treatment of multiple sclerosis 2024

Therapeutic capability of selected medicinal plants' bioactive constituents against the mutant ovarian TP53 gene; a computational approach 2023

Targeting allosteric sites on PDK-1 and PLK-1 with bioactive compounds from Daucus carota as a potential therapy for triple-negative breast cancer 2023